APA

Kempf D. J., Waring J. F., Morfitt D. C., Werner P., Ebert B., Mitten M., Nguyen B., Randolph J. T., DeGoey D. A., Klein L. L. & Marsh K. (20060323). Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitors. : Antimicrobial agents and chemotherapy.

Chicago

Kempf Dale J, Waring Jeffrey F, Morfitt David C, Werner Paige, Ebert Brian, Mitten Michael, Nguyen Bach, Randolph John T, DeGoey David A, Klein Larry L and Marsh Kennan. 20060323. Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitors. : Antimicrobial agents and chemotherapy.

Harvard

Kempf D. J., Waring J. F., Morfitt D. C., Werner P., Ebert B., Mitten M., Nguyen B., Randolph J. T., DeGoey D. A., Klein L. L. and Marsh K. (20060323). Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitors. : Antimicrobial agents and chemotherapy.

MLA

Kempf Dale J, Waring Jeffrey F, Morfitt David C, Werner Paige, Ebert Brian, Mitten Michael, Nguyen Bach, Randolph John T, DeGoey David A, Klein Larry L and Marsh Kennan. Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitors. : Antimicrobial agents and chemotherapy. 20060323.